S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
S&P 500   5,149.42
DOW   38,790.43
QQQ   437.48
3 Large-Cap Stocks Buying Back Shares Aggressively
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Here’s Why Bitcoin Miners Stopped Rising With Bitcoin Prices
2 Deep Value, High Yield Stocks With a Double-Digit Upside
3 Stocks About to Boom on Unusual Call Option Volume
How major US stock indexes fared Monday, 3/18/2024
Oil Prices Up Again, Should You Buy This Time?
NYSE:SYK

Stryker (SYK) Stock Price, News & Analysis

$354.08
+1.85 (+0.53%)
(As of 03/18/2024 ET)
Today's Range
$352.62
$355.92
50-Day Range
$303.41
$358.42
52-Week Range
$249.98
$361.41
Volume
953,204 shs
Average Volume
1.36 million shs
Market Capitalization
$134.53 billion
P/E Ratio
42.92
Dividend Yield
0.90%
Price Target
$331.52

Stryker MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.79 Rating Score
Upside/​Downside
6.4% Downside
$331.52 Price Target
Short Interest
Healthy
1.05% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.95
Upright™ Environmental Score
News Sentiment
0.64mentions of Stryker in the last 14 days
Based on 18 Articles This Week
Insider Trading
Selling Shares
$72.85 M Sold Last Quarter
Proj. Earnings Growth
11.64%
From $11.86 to $13.24 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.83 out of 5 stars

Medical Sector

45th out of 947 stocks

Surgical & Medical Instruments Industry

7th out of 99 stocks

SYK stock logo

About Stryker Stock (NYSE:SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

SYK Stock Price History

SYK Stock News Headlines

Validea Detailed Fundamental Analysis - SYK
The only AI company you should be looking at
This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.
SYK May 17th Options Begin Trading
Stryker Unusual Options Activity
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Stryker (NYSE:SYK) Reaches New 1-Year High at $361.41
Memory Care Communities Near Stryker, OH
Assisted Living Communities Near Stryker, OH
Senior Living Communities Near Stryker, OH
Stryker price target raised by $45 at Argus, here's why
Thermo Fisher (TMO) Introduces Dionex Inuvion IC system
See More Headlines
Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/31 Dividend
12/28/2023
Last Earnings
1/30/2024
Dividend Payable
1/31/2024
Today
3/18/2024
Ex-Dividend for 4/30 Dividend
3/27/2024
Dividend Payable
4/30/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
CUSIP
86366710
Employees
52,000
Year Founded
1941

Price Target and Rating

Average Stock Price Target
$331.52
High Stock Price Target
$364.00
Low Stock Price Target
$292.00
Potential Upside/Downside
-6.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

Net Income
$3.17 billion
Pretax Margin
17.92%

Debt

Sales & Book Value

Annual Sales
$20.50 billion
Cash Flow
$13.35 per share
Book Value
$48.94 per share

Miscellaneous

Free Float
357,522,000
Market Cap
$134.53 billion
Optionable
Optionable
Beta
0.89

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Should I Buy Stryker Stock? SYK Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Stryker was last updated on Friday, March 15, 2024 at 3:01 AM.

Pros

Here are some ways that investors could benefit from investing in Stryker Co.:

  • Stryker Co. has a strong presence in the medical technology industry, offering a wide range of products used in various medical specialties.
  • The company operates through segments like MedSurg and Neurotechnology, and Orthopaedics and Spine, providing diversified revenue streams.
  • Recent institutional investments in Stryker Co., such as Banque Pictet & Cie SA increasing its stake, indicate confidence in the company's growth potential.
  • Stryker Co. continues to innovate with new products, including surgical equipment, neurosurgical implants, and minimally invasive solutions, staying competitive in the market.
  • Considering the recent stock price and financial performance, Stryker Co. shows stability and potential for long-term growth, making it an attractive investment option.

Cons

Investors should be bearish about investing in Stryker Co. for these reasons:

  • While Stryker Co. has a strong market presence, the competitive landscape in the medical technology industry is intense, leading to potential challenges in maintaining market share.
  • Fluctuations in healthcare policies and regulations could impact Stryker Co.'s operations and financial performance, posing risks to investors.
  • Recent insider selling activities, such as Director Ronda E. Stryker selling a significant number of shares, may raise concerns about the company's future prospects.
  • Dependency on third-party dealers and distributors in approximately 75 countries exposes Stryker Co. to geopolitical and economic risks that could affect its global operations.
  • Investors should carefully monitor any changes in the competitive landscape, regulatory environment, and company developments to make informed decisions regarding investing in Stryker Co.

SYK Stock Analysis - Frequently Asked Questions

Should I buy or sell Stryker stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SYK shares.
View SYK analyst ratings
or view top-rated stocks.

What is Stryker's stock price target for 2024?

14 equities research analysts have issued twelve-month price objectives for Stryker's stock. Their SYK share price targets range from $292.00 to $364.00. On average, they anticipate the company's stock price to reach $331.52 in the next year. This suggests that the stock has a possible downside of 6.4%.
View analysts price targets for SYK
or view top-rated stocks among Wall Street analysts.

How have SYK shares performed in 2024?

Stryker's stock was trading at $299.46 on January 1st, 2024. Since then, SYK stock has increased by 18.2% and is now trading at $354.08.
View the best growth stocks for 2024 here
.

When is Stryker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our SYK earnings forecast
.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) announced its quarterly earnings data on Tuesday, January, 30th. The medical technology company reported $3.46 EPS for the quarter, beating analysts' consensus estimates of $3.27 by $0.19. The medical technology company earned $5.82 billion during the quarter, compared to the consensus estimate of $5.60 billion. Stryker had a net margin of 15.44% and a trailing twelve-month return on equity of 22.99%. Stryker's revenue was up 11.8% compared to the same quarter last year. During the same period last year, the business posted $3.00 EPS.
Read the conference call transcript
.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Wednesday, February 7th. Investors of record on Friday, March 29th will be paid a dividend of $0.80 per share on Tuesday, April 30th. This represents a $3.20 annualized dividend and a yield of 0.90%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for SYK
.

Is Stryker a good dividend stock?

Stryker (NYSE:SYK) pays an annual dividend of $3.20 per share and currently has a dividend yield of 0.90%. The company has been increasing its dividend for 31 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 38.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SYK will have a dividend payout ratio of 24.17% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SYK.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its FY 2024 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of 11.700-12.000 for the period, compared to the consensus earnings per share estimate of 11.560. The company issued revenue guidance of -.

What is Kevin A. Lobo's approval rating as Stryker's CEO?

1,492 employees have rated Stryker Chief Executive Officer Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among the company's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

Who are Stryker's major shareholders?

Stryker's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.20%), Greenleaf Trust (4.87%), Price T Rowe Associates Inc. MD (3.30%), Wellington Management Group LLP (3.20%), Capital Research Global Investors (2.69%) and Franklin Resources Inc. (1.23%). Insiders that own company stock include Allan C Golston, Glenn S Boehnlein, James Andrew Pierce, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Ronda E Stryker, Srikant M Datar, Viju Menon and William E Berry Jr.
View institutional ownership trends
.

How do I buy shares of Stryker?

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Stryker have any subsidiaries?
The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Vocera Communications, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.
Read More
This page (NYSE:SYK) was last updated on 3/19/2024 by MarketBeat.com Staff

From Our Partners